https://alsnewstoday.com/news/focus-c9-clinical-trial-advances-complete-data-due-1st-half-2023/
0
0
11/29/22 at 1:00pm
Organization
ALS News Today
A trial investigating WVE-004 in ALS and frontotemporal dementia with C9orf72 mutations will now evaluate a quarterly dose of the medicine.
Create an account
or login to join the discussion